A bitter pill for pharma
May 14, 2021
2 minutes
Shares in pharmaceutical companies slumped last week after the US government “threw its weight behind global plans for a patent waiver on Covid-19 vaccines to boost their production and distribution around the world”, says Julia Kollewe in The Guardian. Vaccine makers Moderna and Novavax fell
You’re reading a preview, subscribe to read more.
Start your free 30 days